15250-m-cuypers

104 Chapter 5 34. Feldman-Stewart D, Brundage M, Siemens R, Skarasgard D. A randomized controlled trial comparing two educational booklets on prostate cancer. Can J Urol. 2006;13(6):3321. 35. Berry DL, Halpenny B, Hong F, Wolpin S, Lober WB, Russell KJ et al., editors. The Personal Patient Profile-Prostate decision support for men with localized prostate cancer: A multi- center randomized trial. Urol Onco; 2013; 31:1012-21. 36. Hacking B, Wallace L, Scott S, Kosmala‐Anderson J, Belkora J, McNeill A. Testing the feasibility, acceptability and effectiveness of a ‘decision navigation’ intervention for early stage prostate cancer patients in Scotland–a randomised controlled trial. Psycho‐Oncology. 2013;22(5):1017-24. 37. Brehaut JC, O'Connor AM,WoodTJ, HackTF, Siminoff L, Gordon E et al. Validation of a decision regret scale. Med Decis Making. 2003;23(4):281-92. 38. Deber RB, Kraetschmer N, Irvine J. What role do patients wish to play in treatment decision- making? Arch Intern Med. 1996;156(13):1414-20. 39. Bennett C, Graham ID, Kristjansson E, Kearing SA, Clay KF, O’Connor AM. Validation of a preparation for decision-making scale. Patient Educ Couns. 2010;78(1):130-3. 40. Llewellyn CD, Horne R, McGurk M, Weinman J. Development and preliminary validation of a new measure to assess satisfaction with information among head and neck cancer patients: the satisfaction with cancer information profile (SCIP). Head Neck. 2006;28(6):540-8. 41. Sepucha K. Decision Quality Worksheet: For Treating Prostate Cancer v.1.0. Massachusetts General Hospital. 2010. http://www.massgeneral.org/decisionsciences/research/DQ_ Instrument_List.aspx. Accessed 1 October 2014. 42. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85(5):365-76. 43. Van Andel G, Bottomley A, Fosså SD, Efficace F, Coens C, Guerif S et al. An international field study of the EORTC QLQ-PR25: a questionnaire for assessing the health-related quality of life of patients with prostate cancer. Eur J Cancer. 2008;44(16):2418-24. 44. Uebersax JS, Wyman JF, Shumaker SA, McClish DK. Short forms to assess life quality and symptomdistress for urinary incontinence inwomen: the Incontinence ImpactQuestionnaire and the Urogenital Distress Inventory. Neurourol Urodyn. 1995;14(2):131-9. 45. Moore KN, Jensen L. Testing of the Incontinence Impact Questionnaire (IIQ‐7)With Men After Radical Prostatectomy. Wound Ostomy Continence Nurs. 2000;27(6):304-12. 46. Bloem S, Stalpers J. Subjective Experienced Health as a Driver of Health Care Behavior. Nyenrode Research Paper Series. 2012; 12: 1-19. 47. Stacey D, Légaré F, Col NF, Bennett CL, Barry MJ, Eden KB et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev. 2014;1: 1-265. 48. Levy H, Ubel PA, Dillard AJ, Weir DR, Fagerlin A. Health Numeracy The Importance of Domain in Assessing Numeracy. Med Decis Making. 2013; 34:107-15. 49. Chew LD, Bradley KA, Boyko EJ. Brief questions to identify patients with inadequate health literacy. Fam Med. 2004; 36:588-594.

RkJQdWJsaXNoZXIy MTk4NDMw